Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs

Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs

Abstract Purpose Plasma-Lyte is a balanced, crystalloid intravenous fluid which has been shown to avoid the hyperchloremic metabolic acidosis associated with 0.9% sodium chloride. Data on physical, pH and chemical compatibility with other medicines are essential. Methods The compatibility of adrenal...

Full description

Bibliographic Details
Main Authors: Sophie Hammond, Andrew Wignell, Paul Cooling, David A. Barrett, Patrick Davies
Format: Article
Language:English
Published: SpringerOpen 2020-06-01
Series:Intensive Care Medicine Experimental
Subjects:
Plasmalyte
Compatibility
Intensive care
Pharmacostability
Drug stability
Online Access:http://link.springer.com/article/10.1186/s40635-020-00311-5

Internet

http://link.springer.com/article/10.1186/s40635-020-00311-5

Similar Items